- Home
- ENR vs ZLAB Comparison
ENR vs ZLAB Comparison
Compare ENR & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENR
- ZLAB
- Stock Information
- Founded
- ENR 2015
- ZLAB 2013
- Country
- ENR United States
- ZLAB China
- Employees
- ENR N/A
- ZLAB N/A
- Industry
- ENR Industrial Machinery/Components
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- ENR Miscellaneous
- ZLAB Health Care
- Exchange
- ENR Nasdaq
- ZLAB Nasdaq
- Market Cap
- ENR 1.5B
- ZLAB 3.6B
- IPO Year
- ENR N/A
- ZLAB 2017
- Fundamental
- Price
- ENR $22.75
- ZLAB $32.54
- Analyst Decision
- ENR Hold
- ZLAB Buy
- Analyst Count
- ENR 8
- ZLAB 5
- Target Price
- ENR $31.63
- ZLAB $54.28
- AVG Volume (30 Days)
- ENR 1.2M
- ZLAB 781.8K
- Earning Date
- ENR 08-05-2025
- ZLAB 08-05-2025
- Dividend Yield
- ENR 5.26%
- ZLAB N/A
- EPS Growth
- ENR N/A
- ZLAB N/A
- EPS
- ENR 0.74
- ZLAB N/A
- Revenue
- ENR $2,901,700,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- ENR $1.77
- ZLAB $44.07
- Revenue Next Year
- ENR $1.63
- ZLAB $49.13
- P/E Ratio
- ENR $30.72
- ZLAB N/A
- Revenue Growth
- ENR 0.39
- ZLAB 43.72
- 52 Week Low
- ENR $19.70
- ZLAB $16.01
- 52 Week High
- ENR $39.52
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- ENR 60.50
- ZLAB 40.19
- Support Level
- ENR $20.96
- ZLAB $34.26
- Resistance Level
- ENR $23.02
- ZLAB $35.72
- Average True Range (ATR)
- ENR 0.62
- ZLAB 1.12
- MACD
- ENR 0.39
- ZLAB -0.54
- Stochastic Oscillator
- ENR 91.72
- ZLAB 3.83
About ENR Energizer Holdings Inc.
Energizer Holdings Inc makes and distributes household batteries, specialty batteries, and lighting products. Energizer offers batteries using lithium, alkaline, carbon-zinc, nickel-metal hydride, zinc-air, and silver oxide technologies. These products are sold under the Energizer, Rayovac, Varta and Eveready brands at performance and premium price segments. It also offers auto care products in the appearance, fragrance, performance, and air conditioning recharge product categories. The company operates in two geographical segments: Americas and International, of which the majority of its revenue is derived from the America. It has two product segments: Batteries & Lights and Auto Care. It earns maximum revenue from Batteries & Lights segment.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.